Evidence map›Paper›PMID 32449612›Full record

ArticleESC heart failure2020

Coffee and tea consumption in the early adult lifespan and left ventricular function in middle age: the CARDIA study.

Chike C Nwabuo, Aisha S Betoko, Jared P Reis, Henrique T Moreira, Henrique D Vasconcellos, Eliseo Guallar, Christopher Cox, Stephen Sidney, Bharath Ambale-Venkatesh, Cora E Lewis and 5 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 2 countries.

Chike C NwabuoDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Aisha S BetokoDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Jared P ReisNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Henrique T MoreiraDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Henrique D VasconcellosDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Eliseo GuallarDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Christopher CoxDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Stephen SidneyDivision of Research, Kaiser Permanente, Oakland, CA, USA.
Bharath Ambale-VenkateshDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Cora E LewisSchool of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Pamela J SchreinerSchool of Public Health, University of Minnesota, Minneapolis, MN, USA.
Donald Lloyd-JonesFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Catarina I KiefePopulation and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
Samuel S GiddingNemours Cardiac Center, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA.
João A C LimaDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Johns Hopkins Medicine · USJohns Hopkins University · USAlfred I. duPont Hospital for Children · USKaiser Permanente Oakland Medical Center · USNational Heart Lung and Blood Institute · USNorthwestern University · USUniversidade de São Paulo · BRUniversity of Alabama at Birmingham · USUniversity of Massachusetts Chan Medical School · USUniversity of Minnesota · US

Funding

NHLBI NIH HHS HHSN268201800003INHLBI NIH HHS HHSN268201800004INHLBI NIH HHS HHSN268201800005INHLBI NIH HHS HHSN268201800006INHLBI NIH HHS HHSN268201800007I
6 · The paper itself

Abstract

aimsThe long-term impact of coffee or tea consumption on subclinical left ventricular (LV) systolic or diastolic function has not been previously studied. We examined the association between coffee or tea consumption beginning in early adulthood and cardiac function in midlife. METHODS AND

resultsWe investigated 2735 Coronary Artery Risk Development in Young Adults (CARDIA) study participants with long-term total caffeine intake, coffee, and tea consumption data from three visits over a 20 year interval and available echocardiography indices at the CARDIA Year-25 exam (2010-2011). Linear regression models were used to assess the association between caffeine intake, tea, and coffee consumption (independent variables) and echocardiography outcomes [LV mass, left atrial volume, and global longitudinal strain (GLS), LV ejection fraction (LVEF), and transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity (E/e´)]. Models were adjusted for standard cardiovascular risk factors, socioeconomic status, physical activity, alcohol use, and dietary factors (calorie intake, whole and refined grain intake, and fruit and vegetable consumption). Mean (standard deviation) age was 25.2 (3.5) years at the CARDIA Year-0 exam (1985-1986), 57.4% were women, and 41.9% were African-American. In adjusted multivariable linear regression models assessing the relationship between coffee consumption and GLS, beta coefficients when comparing coffee drinkers of <1, 1-2, 3-4, and >4 cups/day with non-coffee drinkers were β = -0.30%, P < 0.05; β = -0.35%, P < 0.05; β = -0.32%, P < 0.05; β = -0.40%, P > 0.05; respectively (more negative values implies better systolic function). In adjusted multivariable linear regression models assessing the relationship between coffee consumption and E/e´, beta coefficients when comparing coffee drinkers of <1, 1-2, 3-4, and >4 cups/day with non-coffee drinkers were β = -0.29, P < 0.05; β = -0.38, P < 0.01; β = -0.20, P > .05; and β = -0.37, P > 0.05, respectively (more negative values implies better diastolic function). High daily coffee consumption (>4 cups/day) was associated with worse LVEF (β = -1.69, P < 0.05). There were no associations between either tea drinking or total caffeine intake and cardiac function (P > 0.05 for all).

conclusionsLow-to-moderate daily coffee consumption from early adulthood to middle age was associated with better LV systolic and diastolic function in midlife. High daily coffee consumption (>4cups/day) was associated with worse LV function. There was no association between caffeine or tea intake and cardiac function.

Indexed as

CoffeeVentricular Function, LeftAdultFemaleHumansLongevityMaleMiddle AgedStroke VolumeTeaYoung AdultCoffeeTeacaffeineCoffeeLeft ventricleLeft ventricular functionTea

Identifiers

PMID32449612
PMCPMC7373924
OpenAlexW3027277156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.